PFE · Pfizer Inc

$26.79 -0.01 (-0.04%) At close · Aug 14

Market Cap

$152.69B

5.70B

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$6,800,000,000

as of 2019-02-28 · not restated in filings since 2022-02-24

Remaining Authorization

$3,300,000,000

as of 2026-08-04 · from 8-K (reviewed)

Program Utilization

51.5% $3,500,000,000 used of $6,800,000,000

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2024-12-31	$0	—	—	10-K, filed 2025-02-27
2023-12-31	$0	—	—	10-K, filed 2025-02-27
2022-12-31	$2,000,000,000	39,000,000	—	10-K, filed 2025-02-27
2021-12-31	$0	0	—	10-K, filed 2024-02-22
2020-12-31	$0	0	—	10-K, filed 2023-02-23
2019-12-31	$8,865,000,000	213,000,000	—	10-K, filed 2022-02-24
2018-12-31	$12,198,000,000	307,000,000	—	10-K, filed 2021-02-25
2017-12-31	$5,000,000,000	150,000,000	—	10-K, filed 2020-02-27
2016-12-31	$5,000,000,000	154,000,000	—	10-K, filed 2019-02-28
2015-12-31	$6,160,000,000	182,000,000	—	10-K, filed 2018-02-22
2014-12-31	$5,000,000,000	165,000,000	—	10-K, filed 2017-02-23
2013-12-31	$16,290,000,000	563,000,000	—	10-K, filed 2016-02-29
2012-12-31	$8,228,000,000	349,000,000	—	10-K, filed 2015-02-27
2011-12-31	$9,000,000,000	459,000,000	—	10-K, filed 2014-02-28
2010-12-31	$1,000,000,000	61,000,000	—	10-K, filed 2013-02-28
2009-12-31	$0	—	—	10-K, filed 2010-02-26
2008-12-31	$500,000,000	—	—	10-K, filed 2011-02-28
2007-12-31	$9,994,000,000	—	—	10-K, filed 2010-02-26

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2023-12-31	$0 Δ	—	—	10-K, filed 2025-02-27
2023-10-01	$0 Δ	—	—	10-Q, filed 2023-11-08
2023-07-02	$0 Δ	—	—	10-Q, filed 2023-08-09
2023-04-02	$0	—	—	10-Q, filed 2023-05-10
2022-12-31	$0 Δ	—	—	10-K, filed 2025-02-27
2022-10-02	$0 Δ	—	—	10-Q, filed 2023-11-08
2022-07-03	$0 Δ	—	—	10-Q, filed 2023-08-09
2022-04-03	$2,000,000,000	39,000,000	—	10-Q, filed 2023-05-10
2021-12-31	$0 Δ	—	—	10-K, filed 2024-02-22
2021-10-03	$0 Δ	—	—	10-Q, filed 2022-11-09
2021-07-04	$0 Δ	—	—	10-Q, filed 2022-08-10
2021-04-04	$0	—	—	10-Q, filed 2022-05-11

Key facts CIK 78003 CUSIP 717081103 13F (30d) 2434 filings 2348 filers Visit website Investor relations